Invesco
OKUR

Invesco’s OnKure Therapeutics OKUR Stock Holding History

Invesco’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.2K Buy
+13,636
New +$58.5K ﹤0.01% 3781
2023
Q4 		– Sell
-44,936
Closed -$3.42M – 3906
2023
Q3 		$3.42M Buy
+44,936
New +$3.06M ﹤0.01% 2391

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's OKUR Position: Q2 2026 in Review

Invesco opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 13,636 shares worth $62.2K. The stake represents ﹤0.01% of the portfolio and ranks #3781 among its holdings. This is a return to the name: Invesco previously reported a position in OKUR as recently as Q3 2023.

Invesco first reported a position in OKUR in Q3 2023 and has held it in 2 quarters since. The position peaked at $3.42M in Q3 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Invesco held 13,636 shares of OnKure Therapeutics worth $62.2K as of Q2 2026.
  • OnKure Therapeutics was a new Invesco position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3781 holding.
  • Invesco first reported a position in OnKure Therapeutics in Q3 2023 and has held it in 2 quarters since.
  • Invesco's OnKure Therapeutics position peaked at $3.42M in Q3 2023.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.